Showing results (1501-1510 of 2,149) with videos related to
Sort By:
Pageof 215
Journal of Ovarian Research|July 4, 2025
Human endogenous retrovirus-K envelope protein is aberrantly expressed in serous ovarian cancer and promotes chemosensitivity via NF-κB/P-glycoprotein pathway inhibitionQue Thanh Thanh Nguyen, Soo-Gui Shin, Tra Tran Thu Nguyen, et al.Journal of Ovarian Research|July 3, 2025
Successful treatment of Heyan Kuntai capsule combined with hormonal therapy in an adolescent with diminished ovarian reserve: a case reportXue Ao, Ling Xiong, Jialu Zhu, et al.Journal of Ovarian Research|October 15, 2025
Development of a recurrence-related gene signature and functional role of MLLT6 in ovarian cancer progression and Paclitaxel resistanceQiufang Bao, Shaoyu Wang, Linliang HongJournal of Ovarian Research|September 27, 2025
Mechanism of Zuogui pill in the treatment of polycystic ovary syndrome based on LC-MS and proteomicsYuxuan Ke, Yiting Tang, Jiajing He, et al.Journal of Ovarian Research|May 14, 2025
Effects of melatonin in polycystic ovary syndrome: is there Hippo pathway crosstalk?Lijun Wang, Yuanyuan Jin, Yuanyuan Zhi, et al.Journal of Ovarian Research|May 10, 2025
Proanthocyanidins delaying the premature ovarian insufficiency through regulatory sirt1-p53-p21 signaling pathway in female germline stem cellsWenbo Wu, Mengying Bai, Wenli Hong, et al.Journal of Ovarian Research|July 23, 2025
Determination of high-grade serous ovarian cancer stem cell-based subtypes and prognostic model and identification of highly expressed VSIG4 and STAB1 in macrophagesHuijuan Wu, Dan Li, Lu Sun, et al.Journal of Ovarian Research|July 30, 2025
SLC4A11 is a targetable marker correlated with therapeutic responses in ovarian cancerXin Li, Jia Yuan, Fanchen Wang, et al.Journal of Ovarian Research|August 2, 2025
Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomizationTing Liu, Xiaoqian Tuo, Huifang Zhao, et al.Journal of Ovarian Research|May 5, 2025
Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapyMenglei Zhang, Yuanyuan Gu, Fang Shen, et al.Pageof 215